Clinical decision algorithm developed by the Canadian Cardiovascular Society to guide antithrombotic therapy for patients with nonvalvular atrial fibrillation or atrial flutter. Uses age-based approach to determine whether patients should receive oral anticoagulation, antiplatelet therapy, or no antithrombotic therapy for stroke prevention.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The CHADS-65 (Canadian Society of Cardiology Guideline) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Age ≥65 or CHADS₂ risk factors present
Age <65, no CHADS₂ risk factors, vascular disease present
Age <65, no CHADS₂ risk factors, no vascular disease
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.